News Medical on MSN9h
SolasCure Enrols First Patient in a Next Phase II Clinical Trial to Advance Aurase Wound GelSOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today ...
Daily Post Nigeria on MSN3d
Awoniyi enrols at PFA business schoolNigeria striker Taiwo Awoniyi is currently preparing for life after football by enrolling in a Sporting Directorship course ...
Clinical Trials Arena on MSN3d
Vir enrols first subject in Phase III programme to assess CHD therapyVir Biotechnology has enrolled the first subject in the Phase III ECLIPSE registrational programme of tobevibart and ...
GlobalData on MSN4d
Cantargia enrols first patient in trial of nadunolimab for AML and MDSSwedish company Cantargia has enrolled the first patient in the Phase Ib/IIa trial of nadunolimab for treating individuals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback